How Will The Large Molecule Bioanalytical Technologies Market Expand At A CAGR Of 13.4% Through 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The Large Molecule Bioanalytical Technologies Market?
The market for large molecule bioanalytical technologies has witnessed a swift expansion of late. It is projected to surge from $10.19 billion in 2024, to $11.67 billion in 2025, with a compound annual growth rate (CAGR) of 14.6%. The historical period saw the growth being fuelled by ramped up investment in biotechnology research, burgeoning proteomics research, a spike in high-throughput screening, more prevalent use of next-generation sequencing and a rise in the adoption of single-cell analysis.
Expectations are high for a swift expansion in the large molecule bioanalytical technologies market size within the upcoming years, with projections pointing to a value of $19.28 billion in 2029 at an impressive compound annual growth rate (CAGR) of 13.4%. This expected surge during the forecast period can be linked to a rising demand for biopharmaceuticals, an increase in life sciences research investment, a growing emphasis on point-of-care testing, and an uptick in chronic diseases. Additionally, the heightened demand for biologics and biosimilars also contributes. Key trends forecasted for this period include real-time analysis, more quality control labs, the integration of artificial intelligence, technology advancements, the adoption of cloud-based solutions, and digital technologies’ wider acceptance.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15596&type=smp
What Drivers Are Accelerating Expansion Of The Large Molecule Bioanalytical Technologies Market?
As personalized medical treatments continue to gain traction, it is predicted that the growth of the large molecule bioanalytical technologies market will be significantly accelerated. Personalized medicine encapsulates individualized medical and healthcare interventions tailored to a patient’s unique characteristics, ranging from genetic composition and biomarkers to lifestyle and environmental influences, to optimize effectiveness and minimize adverse reactions. The escalating emphasis on personalized medicine is boosted by variations in individual disease vulnerabilities, a shift towards outcome-based healthcare, and emphasis on patient-focused care. Large molecule bioanalytical technologies are deployed in drug development for the analysis of pharmacokinetics and pharmacodynamics of large-molecule medications, including monoclonal antibodies or gene therapies. For example, in February 2024, the Personalized Medicine Coalition, a non-profit organization based in the US, reported that the FDA endorsed 16 new personalized drugs for patients with rare diseases in 2023, a marked increase from six in 2022. As a result, the burgeoning focus on personalized medicine is fueling the expansion of the large molecule bioanalytical technologies market.
What Are The Primary Segmentation Parameters In The Large Molecule Bioanalytical Technologies Market?
The large molecule bioanalytical technologiesmarket covered in this report is segmented –
1) By Product And Services: Products; Services
2) By Technology: Chromatography; Mass Spectrometry; Enzyme-Linked Immunosorbent Assay; Electrophoresis; Polymerase Chain Reaction; Western Blot; Flow Cytometry; Spectrometer; Other Technologies
3) By Application: Biologics; Oligonucleotide Derived Drugs And Molecules; Viral Vector; Cell And Gene Therapy; Nanoparticles And Polymers; Disease Diagnosis; Other Applications
Subsegments:
1) By Products – Instruments ( Mass Spectrometers, Chromatography Systems, Immunoassay Analyzers); Reagents And Consumables ( Antibodies, Enzyme-Linked Immunosorbent Assay (Elisa) Kits); Software ( Data Analysis And Visualization Software)
2) By Services – Analytical Testing Services; Contract Research Organization (Cro) Services; Method Development And Validation Services; Stability Testing Services; Consulting And Training Services
How Are Market Trends Influencing Competition In The Large Molecule Bioanalytical Technologies Market?
Leading organizations in the large molecule bioanalytical technologies market are innovating advanced techniques such as Fourier transform infrared spectroscopy to elevate the study and identification of large molecules. This technique is utilized in large-molecule bioanalytical technology to ascertain the chemical architecture of biomolecules. For example, in April 2022, Edinburgh Instruments Ltd., a renowned company for scientific instrumentation based in the UK, unveiled the IR5, a benchtop Fourier transform infrared (FTIR) spectrometer. This semiconductor device is crafted for molecular spectroscopy applications and boasts features such as elevated sensitivity and spectrum resolution. Additionally, it incorporates a secondary detector for enhanced sensitivity and employs Fourier transform photoluminescence (FT-PL) for integrated absorption and photoluminescence spectroscopy. The IR5 is equipped with the specifically designed Miracle software which offers a contemporary, potent, and user-friendly experience.
Which Players Are Shaping The Competitive Landscape Of The Large Molecule Bioanalytical Technologies Market?
Major companies operating in the large molecule bioanalytical technologies market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Charles River Laboratories International Inc., Intertek Group plc, Shimadzu Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., HORIBA Ltd., SCIEX, Bio-Techne Corporation, Hamilton Company, Promega Corporation, Verder Group, Solvias AG, Analytik Jena AG, Genedata AG, Wyatt Technology Corporation, Nanalysis Corporation, Avomeen Analytical Services, Cergentis B.V., Halo Labs Inc., Hitachi High-Technologies Corporation, Precision NanoSystems Inc.
Access The Complete Report Here:
What Are The Emerging Regional Trends Driving The Large Molecule Bioanalytical Technologies Market?
North America was the largest region in the large molecule bioanalytical technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large molecule bioanalytical technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15596&type=smp
Browse Through More Reports Similar to the Global Large Molecule Bioanalytical Technologies Market 2025, By The Business Research Company
Small Molecule Injectable Drugs Global Market Report 2025
Small Molecule Drug Discovery Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report
Small Molecule Innovator Cdmo Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/small-molecule-innovator-cdmo-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
